Histological characteristics of the index lesion in whole-mount radical prostatectomy specimens: Implications for focal therapy

Prostate Cancer and Prostatic Diseases

Volumn 14, Issue 1, 2011, Pages 46-52

  Karavitakis, M ^a,b   Winkler, M ^c   Abel, P ^a,c   Livni, N ^c   Beckley, I ^c   Ahmed, H U ^d  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Department of Urology   (Greece)

^c CHARING CROSS HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

high intensity focused; prostatic neoplasm; transrectal; ultrasound

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; TUMOR ABLATION; TUMOR VOLUME; UNITED KINGDOM;

AGED; COHORT STUDIES; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT SELECTION; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 77958032391     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2010.16     Document Type: Article

References (27)

1. Ahmed HU, Pendse D, Illing R, Allen C, van der Meulen JH, Emberton M. Will focal therapy become a standard of care for men with localized prostate cancer? Nat Clin Pract Oncol 2007; 4: 632-642. (Pubitemid 350020378)
2. Barqawi AB, Crawford ED. The current use and future trends of focal surgical therapy in the management of localized prostate cancer. Cancer J 2007; 13: 313-317.
3. Bostwick DG, Waters DJ, Farley ER, Meiers I, Rukstalis D, Cavanaugh WA et al. Group consensus reports from the Consensus Conference on Focal Treatment of Prostatic Carcinoma, Celebration, Florida, February 24, 2006. Urology 2007; 70 (6 Suppl): 42-44.
4. Djavan B, Susani M, Bursa B, Basharkhah A, Simak R, Marberger M. Predictability and significance of multifocal prostate cancer in the radical prostatectomy specimen. Tech Urol 1999; 5: 139-142. (Pubitemid 29501407)
5. Quintal MM, Magna LA, Guimaraes MS, Ruano T, Ferreira U, Billis A. Prostate cancer pathologic stage pT2b (2002 TNM staging system): does it exist? Int Braz J Urol 2006; 32: 43-47.
6. Langenstroer P, Carroll P, Thrasher JB. Clinical and pathological characteristics of unstageable prostate cancer: analysis of the CaPSURE database. J Urol 2005; 174: 118-120. (Pubitemid 40825689)
7. Gregori A, Vieweg J, Dahm P, Paulson DF. Comparison of ultrasound-guided biopsies and prostatectomy specimens: predictive accuracy of Gleason score and tumor site. Urol Int 2001; 66: 66-71. (Pubitemid 32172970)
8. Mouraviev V, Mayes JM, Sun L, Madden JF, Moul JW, Polascik TJ. Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer. Cancer 2007; 110: 906-910. (Pubitemid 47257670)
9. Chen ME, Johnston DA, Tang K, Babaian RJ, Troncoso P. Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer 2000; 89: 1800-1809.
10. Miller GJ, Cygan JM. Morphology of prostate cancer: the effects of multifocality on histological grade, tumor volume and capsule penetration. J Urol 1994; 152 (5 Pt 2): 1709-1713. (Pubitemid 24322612)
11. Simma-Chiang V, Horn JJ, Simko JP, Chan JM, Carroll PR. Increased prevalence of unifocal prostate cancer in a contemporary series of radical prostatectomy specimens: implications for focal ablation. J Urol 2006; 175: 1163.
12. Ohori M, Eastham JA, Koh H. Is focal therapy reasonable in patients with early stage prostate cancer (CAP)- an analysis of radical prostatectomy (RP) specimens. J Urol 2006; 175 (suppl): 507.
13. Wise AM, Stamey TA, McNeal JE, Clayton JL. Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology 2002; 60: 264-269. (Pubitemid 34831770)
14. Rashid M, Wojno KJ, Marcovich R, Rubin M, Montie JE, Sanda MG. Maximum tumor dimension provides a clinically useful and independently significant measure for predicting PSA-free survival following radical prostatectomy. J Urol 1999; 161 (suppl): 241.
15. Haggman M, Nordin B, Mattson S, Busch C. Morphometric studies of intra-prostatic volume relationships in localized prostatic cancer. Br J Urol 1997; 80: 612-617. (Pubitemid 28316386)
16. Eggener SE, Scardino PT, Carroll PR, Zelefsky MJ, Sartor O, Hricak H et al. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J Urol 2007; 178: 2260-2267. (Pubitemid 350052204)
17. Scardino PT. Focal therapy for prostate cancer. Nat Rev Urol 2009; 6: 175.
18. Chen ME, Johnston D, Reyes AO, Soto CP, Babaian RJ, Troncoso P. A streamlined three-dimensional volume estimation method accurately classifies prostate tumors by volume. Am J Surg Pathol 2003; 27: 1291-1301. (Pubitemid 37185820)
19. Lerner SE, Seay TM, Blute ML, Bergstralh EJ, Barrett D, Zincke H. Prostate specific antigen detected prostate cancer (clinical stage T1c): an interim analysis. J Urol 1996; 155: 821-826. (Pubitemid 26052657)
20. Mouraviev V, Sun L, Madden JF, Mayes JM, Moul JW, Polascik TJ. Prostate cancer laterality does not predict prostate-specific antigen recurrence after radical prostatectomy. Urology 2007; 70: 1141-1145. (Pubitemid 350297374)
21. Ruijter ET, Miller GJ, van de Kaa CA, van Bokhoven A, Bussemakers MJ, Debruyne FM et al. Molecular analysis of multifocal prostate cancer lesions. J Pathol 1999; 188: 271-277. (Pubitemid 29317770)
22. Ruijter ET, van de Kaa CA, Schalken JA, Debruyne FM, Ruiter DJ. Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications. J Pathol 1996; 180: 295-299. (Pubitemid 26393679)
23. Tareen A, Sankin G, Godoy S, Temkin H, Lepor S, Taneja S. Men with unilateral prostate cancer have more favorable pathologic and oncologic outcomes than those with bilateral disease: implications for focal therapy. J Urol 2008; 179 (4 suppl): 396.
24. Magi-Galluzzi C, Roma A, Jones S, Klein E, Zhou M. Pathologic features of single-nodule prostatic carcinoma. Lab Invest 2006; 86: 151A.
25. Noguchi M, Stamey TA,McNeal JE, Nolley R. Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers. J Urol 2003; 170 (2 Pt 1): 459-463. (Pubitemid 36870224)
26. Schmidt H, DeAngelis G, Eltze E, Gockel I, Semjonow A, Brandt B. Asynchronous growth of prostate cancer is reflected by circulating tumor cells delivered from distinct, even small foci, harboring loss of heterozygosity of the PTEN gene. Cancer Res 2006; 66: 8959-8965. (Pubitemid 44521111)
27. Gburek BM, Kollmorgen TA, Qian J, D'Souza-Gburek SM, Lieber MM, Jenkins RB. Chromosomal anomalies in stage D1 prostate adenocarcinoma primary tumors and lymph node metastases detected by fluorescence in situ hybridization. J Urol 1997; 157: 223-227. (Pubitemid 26414963)